Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer.

BACKGROUND: Active surveillance (AS) represents a standard of care of low-risk prostate cancer (PCa). However, the identification and monitoring of AS candidates remains challenging. Microultrasound (microUS) is a novel high-resolution imaging modality for transrectal ultrasonography (TRUS). We explored the impact of microUS TRUS and targeted biopsies in mpMRI-guided confirmatory biopsies. METHODS: Between October 2017 and September 2021, we prospectively enrolled 100 patients scheduled for MRI-guided confirmatory biopsy at 1 year from diagnosis of ISUP 1 PCa. TRUS was performed using the ExactVu microUS system; PRI-MUS protocol was applied to identify suspicious lesions (i.e., PRIMUS score ≥ 3). All patients received targeted biopsies of any identified microUS and mpMRI lesions and complementary systematic biopsies. The proportion of patients upgraded to clinically significant PCa (defined as ISUP ≥ 2 cancer; csPCa) at confirmatory biopsies was determined, and the diagnostic performance of microUS and mpMRI were compared. RESULTS: Ninety-two patients had a suspicious MRI lesion classified PI-RADS 3, 4, and 5 in respectively 28, 16, and 18 patients. MicroUS identified 82 patients with suspicious lesions, classified as PRI-MUS 3, 4, and 5 in respectively 20, 50, and 12 patients, while 18 individuals had no lesions. Thirty-four patients were upgraded to ISUP ≥ 2 cancer and excluded from AS. MicroUS and mpMRI showed a sensitivity of 94.1% and 100%, and an NPV of 88.9% and 100%, respectively, in detecting ISUP ≥ 2 patients. A microUS-mandated protocol would have avoided confirmatory biopsies in 18 patients with no PRI-MUS ≥ 3 lesions at the cost of missing four upgraded patients. CONCLUSIONS: MicroUS and mpMRI represent valuable imaging modalities showing high sensitivity and NPV in detecting csPCa, thus allowing their use for event-triggered confirmatory biopsies in AS patients. MicroUS offers an alternative imaging modality to mpMRI for the identification and real-time targeting of suspicious lesions in AS patients.

Retrograde endopyelotomy using the holmium laser: technical aspects and functional results.

INTRODUCTION: Endopyelotomy is considered standard treatment for primary and secondary ureteropelvic junction obstruction. The aim of this study is to report our initial experience with the retrograde endopyelotomy technique. MATERIALS AND METHODS: Between January 2000 and April 2003 we submitted to retrograde ureteroscopic holmium laser endopyelotomy 16 patients (9 males and 7 females) aged between 22 and 64 years. Obstruction was primary in 10 cases and secondary due to unsuccessful open pyeloplasty in the remaining six. No patient was affected by coexisting urinary lithiasis. Excretory urography and diuretic renal scintigraphy were performed preoperatively in all patients. Endopyelotomy was carried out using the holmium laser which delivered an energy level of 1.2 Joule at 10-15 Hertz. A double J ureteral stent remained indwelling postoperatively for 6 weeks and a vesical catheter for 24 hours. Average operative time was 75 minutes (range 50-90 minutes). Patients were assessed on follow-up by echotomography of the urinary tract and diuretic renal scintigraphy after 3 months and then at 6-month intervals. RESULTS: Patients were assessed on a mean follow-up of 18 months (range 6-41). Outcome was considered successful when symptoms were resolved and renal function improved. Success was obtained in 13 patients. Two patients were submitted to pyeloplasty with positive results and the procedure on one patient was converted to pyeloplasty due to intraoperative haemorrhage. Average postoperative stay was three days (range 1-4). No patient required blood transfusion with postoperative reduction in haematocrit of 0-9%, (mean 3%). Normal daily activity resumed after 3-4 days from discharge. CONCLUSIONS: Retrograde endopyelotomy in our initial experience is a safe and efficient technique that gives an excellent percentage of success with reduced complications and good patient compliance. The retrograde compared with the anterograde approach has the advantage of being less invasive, does not require nephrostomal derivation and further reduces hospital stay.